CASI Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $53.7M
Liabilities Breakdown FY2024
Total Liabilities: $51.8M
Asset Breakdown
Total Assets: $53.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $13.5M | 25.1% |
| Accounts Receivable | $15.3M | 28.6% |
| Inventory | $5.3M | 9.8% |
| Property, Plant & Equipment | $7.9M | 14.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $238.0K | 0.4% |
| Other Assets | $11.5M | 21.4% |
Liabilities Breakdown
Total Liabilities: $51.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.7M | 5.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $49.1M | 94.7% |